secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENANTA PHARMACEUTICALS INC (ENTA)
CIK:        0001177648
Form:       8-K
Filed at:   2025-08-27T23:59:59+00:00
Accession:  0001193125-25-189691
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Enanta designates interim CFO and principal accounting officer during CFO medical leave
--------------------------------------------------------------------------------

- Harry Trout (VP Finance) named interim principal financial officer; Katie Capps (Executive Director, Accounting) interim principal accounting officer.
- Appointments effective Aug 26, 2025, while CFO Paul Mellett is on a medical leave of absence.
- Trout joined Enanta in 2002; Capps joined in 2016; both have held increasing finance roles.
- Neither interim officer has entered into new material plans or arrangements in connection with this appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1177648/000119312525189691/0001193125-25-189691-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1177648/000119312525189691/enta-20250826.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-189691

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer